在儿科患者中使用CytoSorb®的血液输血:一个单心病例系列
Eva Rihar1, Vanja Peršič2,3, Alexander Jerman2
1University Children's Hospital, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.
Journal of clinical medicine
|November 9, 2024
概括
使用CytoSorb (CS) 的体外细胞因子吸附显示出治疗危急儿童细胞因子风暴的前景. 虽然在10公斤以上的儿童中有效,但在较小的儿童中使用它需要进一步研究.
科学领域:
- 关键护理医学 关键护理医学
- 儿科重症监护 儿科重症监护
- 免疫学 免疫学 免疫学
背景情况:
- 细胞因子在调节炎症反应中起着至关重要的作用.
- 一个细胞因子风暴,一个失调的细胞因子反应,导致超炎症状态,通常在败血症中见到.
- 外体细胞因子吸附提供了一个潜在的策略,以重新平衡炎症反应.
研究的目的:
- 为了评估使用CytoSorb (CS) 输血在患有细胞因子风暴的重症儿童的使用.
- 评估CS在这个患者群体中的安全性和初步疗效.
主要方法:
- 一个用CS治疗血输血治疗的八名危急病患儿童的病例系列.
- 在卢布尔雅纳大学医学中心进行治疗.
- 记录了患者的体重和结果.
主要成果:
- 在重量超过10公斤的5名儿童中,CS在没有并发症的情况下被应用,所有儿童都幸存下来.
- 体重小于10公斤的3名患者没有存活.
- 年龄对CS治疗并发症的影响尚不清楚.
结论:
- 与CS一起的细胞因子吸附是一种潜在的辅助疗法,用于重症儿童的细胞因子风暴.
- 需要进一步的研究来澄清患者体重和年龄对CS治疗结果的影响.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Distribution
554
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Metabolism
410
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
377
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
377
Hemodialysis II: Procedure and Complications
2.2K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K


